Kyoto University researchers have regenerated neural stem cells in an adult mouse and improved its cognitive function through its method, dubbed "iPaD."
The test results were equivalent to turning a 60-year-old-human's neural stem cells into those of a teenager.
However, there are challenges in applying the procedure to humans because the mouse’s genetic engineering involved using a virus to inject the genes into the brain.
The research team’s leader, visiting professor Ryoichiro Kageyama, said they would continue to see if the procedure can be applied to humans.
The team will now test its iPaD method on marmosets to determine if its applicability to primates.
The ability to multiply embryonic neural stem cells to increase the number of nerve cells weakens with age. That, in turn, results in reduced cognitive function.
The iPaD method maximizes the activation of the neural stem cells by combining the infant mice’s most active genes with a restraining function of the adult mice’s most active genes.
The engineered neural stem cells in an adult mouse became more active with the neural stem cells continuing to multiply for about three months.
|Consequently, the adult mouse improved its cognitive function with the increase in neural stem cell multiplication.


US Stock Futures Rise as Oil Falls, Nvidia Eyes $250 Billion OpenAI Data Center Deal
Intel, AMD Seek Long-Term China Server CPU Deals as AI Demand Drives Supply Crunch
Gold Prices Rise as Weak Dollar, Fed Rate Decision in Focus
Macquarie Names Greg Ward as CEO, Signaling Stability and Strategic Continuity
Rubio Rejects AI ‘Kill Switch’ Claims as U.S. Defends American Technology Abroad
Volkswagen Cuts 2026 Revenue Outlook as China Weakness, Trade Risks Weigh
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
Intel Stock Slips After Earnings Rally Despite Strong AI-Driven Revenue Growth
Uber Stock Falls as Waymo Plans to End Robotaxi Partnership by 2028
European Stocks Flat as Oil Tops $100, Trump Tariffs Fuel Inflation Fears
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
BOJ Seen Holding Rates at 1% While Keeping Inflation Risk Warning 



